Baird Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $278
Baird Adjusts Price Target on Labcorp Holdings to $278 From $277, Maintains Outperform Rating
JPMorgan Adjusts Price Target on Labcorp Holdings to $271 From $243, Maintains Overweight Rating
Argus Raises Laboratory Corp of America's Price Target to $260 From $250
Mizuho Securities Maintains Labcorp Holdings(LH.US) With Buy Rating
Labcorp Holdings Analyst Ratings
BofA Securities Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $260
Evercore ISI Adjusts Price Target on Laboratory Corp of America to $250 From $215
Morgan Stanley Maintains Labcorp Holdings(LH.US) With Buy Rating, Maintains Target Price $260
Evercore Maintains Labcorp Holdings(LH.US) With Hold Rating, Raises Target Price to $250
Labcorp Holdings Analyst Ratings
A Quick Look at Today's Ratings for Labcorp Holdings(LH.US), With a Forecast Between $240 to $277
Leerink Partners Raises Laboratory Corp of America's Price Target to $259 From $242
Citi Upgrades Illumina, Quest, Agilent to Buy, Downgrades Avantor
Evercore ISI Group Maintains In-Line on Labcorp Holdings, Raises Price Target to $215
Evercore ISI Adjusts Price Target on Laboratory Corp of America Holdings to $215 From $210
Labcorp Holdings Analyst Ratings
Baird Raises Price Target on Laboratory Corp of America to $261 From $258
HSBC Adjusts Price Target on Laboratory Corp of America Holdings to $210 From $225, Keeps Hold Rating
Komo: Maintaining the Labcorp Holdings (LH.US) rating, adjusted from an increase to an increase in holdings rating, and the target price was adjusted from $261.00 to $243.00.